November 18, 2016 - By Richard Conner · 0 Comments
Bovie Medical Corp (NYSEMKT:BVX) institutional sentiment increased to 2.44 in 2016 Q2. Its up 1.90, from 0.54 in 2016Q1. The ratio has increased, as 7 funds opened new or increased holdings, while 13 sold and reduced stock positions in Bovie Medical Corp. The funds in our partner’s database now own: 4.70 million shares, down from 5.02 million shares in 2016Q1. Also, the number of funds holding Bovie Medical Corp in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 7 Reduced: 6 Increased: 5 New Position: 2.
Bovie Medical Corporation is an energy medical device company. The company has a market cap of $133.43 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.
The stock increased 0.69% or $0.03 on November 17, hitting $4.38. Bovie Medical Corporation (NYSEMKT:BVX) has risen 160.71% since April 18, 2016 and is uptrending. It has outperformed by 156.28% the S&P500.
According to Zacks Investment Research, “Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devices and advanced coating technologies.”
Great Point Partners Llc holds 1.26% of its portfolio in Bovie Medical Corporation for 2.68 million shares. Perkins Capital Management Inc owns 355,740 shares or 0.67% of their US portfolio. Moreover, Salem Investment Counselors Inc has 0.01% invested in the company for 29,771 shares. The Kansas-based Vsr Financial Services Inc. has invested 0.01% in the stock. Wasatch Advisors Inc, a Utah-based fund reported 340,000 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 1 insider buy, and 0 selling transactions for $299,475 net activity.
Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy medical device company. The Firm is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. The Firm operates through three divisions: Core, OEM and J-Plasma. The Firm is engaged in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. The Firm offers its products in three categories: electrosurgery, cauteries and other products.
Another recent and important Bovie Medical Corporation (NYSEMKT:BVX) news was published by Seekingalpha.com which published an article titled: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q3 2016 Results …” on October 27, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Richard Conner